What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Diabetes mellitus
- Insulin resistance
Kenneth Cusi mainly focuses on Internal medicine, Endocrinology, Insulin resistance, Diabetes mellitus and Insulin.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Pioglitazone.
His work on Basal, Glucose clamp technique, Insulin receptor and Human physiology as part of his general Endocrinology study is frequently connected to Esterified fatty acid, thereby bridging the divide between different branches of science.
His Insulin resistance research includes elements of Adipose tissue, Steatosis, Skeletal muscle and Fatty liver.
His research in Diabetes mellitus intersects with topics in Glycogen synthase, Peroxisome proliferator-activated receptor and Steatohepatitis.
Kenneth Cusi has researched Type 2 Diabetes Mellitus in several fields, including Liver disease and Metabolic syndrome.
His most cited work include:
- The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association (2522 citations)
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. (2005 citations)
- Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 (1650 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Endocrinology, Insulin resistance, Diabetes mellitus and Nonalcoholic fatty liver disease.
His Internal medicine study incorporates themes from Gastroenterology and Type 2 diabetes, Pioglitazone.
His Type 2 diabetes research incorporates themes from Basal, Glucose tolerance test, Weight loss and Hepatocellular carcinoma.
His studies deal with areas such as Adipose tissue, Steatohepatitis, Type 2 Diabetes Mellitus and Bioinformatics as well as Insulin resistance.
His Diabetes mellitus study integrates concerns from other disciplines, such as Obesity and Intensive care medicine.
His biological study spans a wide range of topics, including Chronic liver disease, Cirrhosis, Liver disease and Liver biopsy.
He most often published in these fields:
- Internal medicine (115.64%)
- Endocrinology (74.90%)
- Insulin resistance (67.08%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (115.64%)
- Nonalcoholic fatty liver disease (60.49%)
- Gastroenterology (42.39%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Nonalcoholic fatty liver disease, Gastroenterology, Type 2 diabetes and Diabetes mellitus.
His studies in Internal medicine integrate themes in fields like Endocrinology and Type 2 Diabetes Mellitus.
His Nonalcoholic fatty liver disease study also includes fields such as
- Liver disease and related Cell adhesion molecule and Pathology,
- Cirrhosis which connect with Metabolic syndrome.
His Type 2 diabetes research is multidisciplinary, incorporating perspectives in Rate ratio, Regimen, Steatohepatitis and Weight loss.
The concepts of his Diabetes mellitus study are interwoven with issues in Nonalcoholic steatohepatitis, Biopsy, Randomized controlled trial and FibroTest.
His Insulin resistance research is classified as research in Insulin.
Between 2018 and 2021, his most popular works were:
- Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. (193 citations)
- Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. (193 citations)
- Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease. (75 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Diabetes mellitus
- Type 2 diabetes
Kenneth Cusi mostly deals with Internal medicine, Diabetes mellitus, Type 2 diabetes, Steatohepatitis and Fatty liver.
His research on Internal medicine frequently links to adjacent areas such as Gastroenterology.
His work carried out in the field of Type 2 diabetes brings together such families of science as Fibrosis and Insulin resistance.
To a larger extent, Kenneth Cusi studies Endocrinology with the aim of understanding Insulin resistance.
The Steatohepatitis study combines topics in areas such as Liver disease and Liver biopsy.
Kenneth Cusi combines subjects such as Insulin and Bioinformatics with his study of Fatty liver.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
